Barcelona, Spain, 13-14 October 2016
The presentations in this page have been archived and are no longer available.
| Topic | Speaker |
|---|---|
| Session 1: Traceability | |
| Traceability in laboratory medicine – current status | Jonathan Middle |
| Effect of traceability – example from an EQA provider | Paul Franck |
| Results of questionnaire on traceability | Piet Meijer |
| Session 2: Adam Uldall Lecture | |
| Elements of analytical quality – a historical review | Per Hyltoft Petersen |
| Session 3: The Perfect EQA Scheme; How might we achieve this? | |
| The road to a perfect EQA programme | Christa Cobbaert |
| What is commutability and how can it be examined? | Finlay MacKenzie |
| The use of target values in EQA | Anja Kessler |
| The importance of reagent lot registration in EQA | Anne Stavelin |
| Session 4: The members' session | |
| Commutable serum with Reference values, impact on standardization | Beatriz Boned and Emma Ventura |
| Interpretation of EQA results and EQA-based trouble shooting | Gunn Kristensen |
| Session 5: Selected presentations from abstracts | |
| First Belgian national EQA for special stains in histopathology | Vanessa Ghislain |
| Anti-viral and antiretroviral drugs assays: results of five years EQAS | Anne Vassault |
| Peer groups with few participants: Novel robust approach for assigned values based on a mixed linear model and ISO 13528 algorithms | Christian Blaeul |